Characterization of an engineered live bacterial therapeutic for the treatment of phenylketonuria in a human gut-on-a-chip
Harnessing Colon Chip Technology to Identify Commensal Bacteria That Promote Host Tolerance to Infection
Mucus production, host-microbiome interactions, hormone sensitivity, and innate immune responses modeled in human cervix chips